Crest Reports Strong Quarter PAT Ahead of Oct 9 Listing
Crest Reports Strong Quarter PAT Ahead of Oct 9 Listing
During the second quarter, the provision of imaging, analytical, and test solutions segment contributed RM32.77 million or 82.7% of total revenue, while the provision of after-sales services segment generated RM6.86 million or 17.3% of total revenue. Crest Group Berhad (Crest) today released its financial results for the second quarter ended 30 June 2024 (Q2/2024) recording RM3.70 million in profit after tax (PAT) on the back of a revenue of RM39.63 million.
Crest集團Berhad（Crest）今天發佈了截至2024年6月30日的第二季度財務業績（Q2/2024），實現稅後利潤（PAT）爲370萬令吉，營業收入爲3963萬令吉。
The group's quarterly performance remains healthy with a gross profit margin of 29.1% and a PAT margin of 9.3%.
該集團的季度表現保持健康，毛利率爲29.1%，稅後利潤率爲9.3%。
For the first six-months of 2024, the group registered total revenue of approximately RM79.28 million and PAT of RM6.62 million. Notably, recognised in the first-half were non-recurring one-off listing expenses of approximately RM2.09 million. After adjusting for the listing expenses, the half-yearly PAT would be RM8.71 million.
2024年上半年，該集團的總營業收入約爲7928萬令吉，稅後利潤爲662萬令吉。值得注意的是，上半年認可的一次性非經常性上市費用約爲209萬令吉。扣除上市費用後，半年稅後利潤將爲871萬令吉。
During the second quarter, the provision of imaging, analytical, and test solutions segment contributed RM32.77 million or 82.7% of total revenue, while the provision of after-sales services segment generated RM6.86 million or 17.3% of total revenue.
在第二季度，成像、分析和測試解決方案部門貢獻了3277萬令吉的總營業收入，佔總營業收入的82.7%，而售後服務部門產生了686萬令吉，佔總營業收入的17.3%。
Within the first two quarters of 2024, the group's imaging, analytical, and test solutions segment contributed a combined RM64.9 million or 81.9% of total revenue and the after-sales services segment contributed RM14.4 million or 18.1% of total revenue.
2024年前兩季度內，集團的成像、分析和測試解決方案部門共貢獻6490萬令吉，佔總營業收入的81.9%，售後服務部門貢獻了1440萬令吉，佔總營業收入的18.1%。
Crest's Managing Director, Mr Lim Siong Wai, commented, "We remain optimistic about our long-term prospects, driven by our strong competitive positioning within the industry. The imaging, analysis, and testing market in Malaysia has seen significant growth, expanding from RM4.33 billion in 2020 to RM7.25 billion in 2023, with a compound annual growth rate of 18.7%."
Crest的董事總經理林祥偉先生評論說：「我們對未來的長期前景保持樂觀，這得益於我們在行業內的競爭定位。馬來西亞的成像、分析和測試市場已經出現顯著增長，從2020年的433億令吉增至2023年的725億令吉，複合年增長率爲18.7%。」
In alignment with the anticipated growth trend, the group plans to open new branch offices in China and Vietnam. In addition, a new centralised headquarters will be established in Selangor to streamline its central region business operations. Also, new investment in advanced imaging and sample management equipment will be undertaken to upgrade its demo room in Malaysia, China and Thailand.
與預期增長趨勢一致，該集團計劃在中國和越南開設新分支機構。此外，將在雪蘭莪州建立新的集中總部，以簡化中央地區業務運營。同時，將進行對其馬來西亞、中國和泰國的示範室進行升級的新投資，更新先進成像和樣品管理設備。
Crest will be officially listed on the ACE Market of Bursa on 9 October 2024.
Crest將於2024年10月9日正式在馬交所創業板上市。
譯文內容由第三人軟體翻譯。